-
公开(公告)号:US06368625B1
公开(公告)日:2002-04-09
申请号:US09372738
申请日:1999-08-11
IPC分类号: A61K920
CPC分类号: A61K9/0007 , A61K9/0056 , A61K9/2009 , A61K9/2054 , A61K9/2081 , A61K9/5042 , A61K9/5047
摘要: A dosage form which rapidly disintegrates in the mouth and forms a viscous slurry of either microcapsules or a powder is described. The rapidly disintegrating dosage form is meant for direct oral administration by placing a tablet or capsule in the mouth of a patient. Upon disintegration, a viscosity of the resulting slurry increases so as to form an organoleptically pleasant viscous material which retards the spread of insoluble materials including the drug.
摘要翻译: 描述了在口中快速崩解并形成微胶囊或粉末的粘性浆液的剂型。 快速崩解的剂型意在通过将片剂或胶囊置于患者的口中直接口服给药。 在分解时,所得浆料的粘度增加,以形成感官愉悦的粘稠材料,其阻止包括药物在内的不溶物质的铺展。
-
公开(公告)号:US06200604B1
公开(公告)日:2001-03-13
申请号:US09327814
申请日:1999-06-08
申请人: Sathasivan Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
发明人: Sathasivan Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
IPC分类号: A61K946
CPC分类号: A61K31/5415 , A61K9/0007 , A61K9/0056 , A61K9/006 , A61K31/4468
摘要: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
摘要翻译: 一种药物剂型,其适于向口腔中提供药物的颊,舌下或牙龈吸收,所述药物包含与用于促进药物在口腔中吸收的口腔可药用组合泡腾剂。 还公开了与泡腾剂结合使用另外的pH调节物质以促进吸收药物。
-
公开(公告)号:US08728441B2
公开(公告)日:2014-05-20
申请号:US13098986
申请日:2011-05-02
申请人: Jonathan D. Eichman , John Hontz , Rajendra K. Khankari , Sathasivan Indiran Pather , Joseph R. Robinson
发明人: Jonathan D. Eichman , John Hontz , Rajendra K. Khankari , Sathasivan Indiran Pather , Joseph R. Robinson
CPC分类号: A61K31/4468 , A61K9/0007 , A61K9/0056 , A61K9/006 , A61K31/5415
摘要: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
-
公开(公告)号:US20090214442A1
公开(公告)日:2009-08-27
申请号:US12246133
申请日:2008-10-06
IPC分类号: A61K9/12 , A61K31/465
CPC分类号: A61K9/006 , A61K9/0007 , A61K9/0056 , A61K9/2009 , A61K9/2013 , A61K31/465
摘要: Described herein are oral transmucosal solid dosage forms useful in treating nicotine addiction or as a nicotine substitute or replacement. By virtue of the formulation in combination with nicotine, the dosage forms transmucosally delivers an effective amount of nicotine to the recipient while permitting the accomplishing of such, and manufacture of such, using a relatively small, convenient and orally comfortable dosage form (e.g., tablet) size.
摘要翻译: 本文描述的是用于治疗尼古丁成瘾或尼古丁替代物或替代物的口腔经粘膜固体剂型。 由于配方与尼古丁组合,所述剂量形式通过粘膜递送有效量的尼古丁至接受者,同时允许使用相对较小,方便和口服舒适的剂型(例如片剂)来实现和制造 )大小。
-
公开(公告)号:US06740341B1
公开(公告)日:2004-05-25
申请号:US09449851
申请日:1999-11-24
申请人: Kris E. Holt , Rajendra K. Khankari , John Hontz
发明人: Kris E. Holt , Rajendra K. Khankari , John Hontz
IPC分类号: A61K914
CPC分类号: A61K9/0056 , A61K9/5073 , Y10S514/974
摘要: The present invention relates to a core containing a drug encased in a spacing layer and a taste masking layer which provides effective taste masking for in-mouth disintegrable dosage forms containing highly objectionable tasting drugs, as well as dosage forms containing these cores.
摘要翻译: 本发明涉及含有间隔层中的药物的核心和掩味层,其对含有高度令人讨厌的品尝药物的口腔内可分解剂型以及含有这些核心的剂型提供有效的掩味。
-
公开(公告)号:US06576250B1
公开(公告)日:2003-06-10
申请号:US09664870
申请日:2000-09-19
申请人: S. Indiran Pather , Joseph R. Robinson , Jonathan D. Eichman , Rajendra K. Khankari , John Hontz
发明人: S. Indiran Pather , Joseph R. Robinson , Jonathan D. Eichman , Rajendra K. Khankari , John Hontz
IPC分类号: A61K902
CPC分类号: A61K9/006 , A61K9/0007 , A61K9/0056 , A61K9/2072 , A61K9/2866 , A61K9/2886 , A61K31/4468 , A61K31/5415
摘要: The pharmaceutical compositions of the present invention comprise rectally and vaginally administerable dosage forms that contain effervescent agents as penetration enhancers for drugs. Effervescence occurs in the rectum or vagina, once the dosage form is administered or at a predetermined time following administration. The effervescent agents can be used alone or in combination with pH adjusting substance, which further promote dissolution and absorption of the active ingredient.
摘要翻译: 本发明的药物组合物包含含有泡腾剂作为药物渗透促进剂的直肠和阴道给药剂型。 在直肠或阴道中发生泡腾,一旦施用剂型或在施用后的预定时间。 泡腾剂可以单独使用或与pH调节物质组合使用,这进一步促进活性成分的溶解和吸收。
-
公开(公告)号:US6024981A
公开(公告)日:2000-02-15
申请号:US57884
申请日:1998-04-09
CPC分类号: A61K9/0007 , A61K9/0056 , A61K9/2018 , Y10S514/951 , Y10S514/96
摘要: The invention is directed to a hard tablet that can be stored, packaged and processed in bulk. Yet the tablet dissolves rapidly in the mouth of the patient with a minimum of grit. The tablet is created from an active ingredient mixed into a matrix of a non-direct compression filler and a relatively high lubricant content.
摘要翻译: 本发明涉及可以批量储存,包装和加工的硬片。 然而,片剂以最少的砂砾迅速溶解在患者的口中。 片剂由混合成非直接压缩填料的基质和较高润滑剂含量的活性成分制成。
-
公开(公告)号:US08802130B2
公开(公告)日:2014-08-12
申请号:US11511098
申请日:2006-08-28
申请人: S. Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
发明人: S. Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
IPC分类号: A61F13/00
CPC分类号: A61K9/0007 , A61K9/0056 , A61K9/006 , A61K31/4468 , A61K31/5415
摘要: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
摘要翻译: 一种药物剂型,其适于向口腔中提供药物的口腔,舌下或牙龈吸收,所述药物包含与可用于促进所述药物在口腔中的吸收的泡腾剂相结合的可口服给药的药物。 还公开了与泡腾剂结合使用另外的pH调节物质以促进吸收药物。
-
公开(公告)号:US20110223115A1
公开(公告)日:2011-09-15
申请号:US13099003
申请日:2011-05-02
申请人: Sathasivan Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
发明人: Sathasivan Indiran Pather , Rajendra K. Khankari , Jonathan D. Eichman , Joseph R. Robinson , John Hontz
IPC分类号: A61K9/10
CPC分类号: A61K31/4468 , A61K9/0007 , A61K9/0056 , A61K9/006 , A61K31/5415
摘要: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
摘要翻译: 一种药物剂型,其适于向口腔中提供药物的口腔,舌下或牙龈吸收,所述药物含有与用于促进口腔中的药物吸收的泡腾剂相结合的可口服给药的药物。 还公开了使用额外的pH调节物质与泡腾剂组合以促进吸收药物。
-
公开(公告)号:US06641838B2
公开(公告)日:2003-11-04
申请号:US10021109
申请日:2001-10-29
申请人: S. Indiran Pather , Joseph R. Robinson , Jonathan D. Eichman , Rajendra K. Khankari , John Hontz , Sangeeta V. Gupte
发明人: S. Indiran Pather , Joseph R. Robinson , Jonathan D. Eichman , Rajendra K. Khankari , John Hontz , Sangeeta V. Gupte
IPC分类号: A61K928
CPC分类号: A61K9/2886 , A61K9/0007 , A61K9/2072 , A61K9/2866 , A61K9/5084 , Y10S514/96
摘要: The pharmaceutical compositions of the present invention comprise orally administerable dosage forms that use effervescence as a penetration enhancer for drugs known, or suspected, of having poor bioavailability. Effervescence can occur in the stomach, once the tablet or other dosage form is ingested. In addition to effervescence in the stomach, or as alternative technique, by the use of appropriate coatings and other techniques, the effervescence can occur in other parts of the gastrointestinal tract, including, but not limited to, the esophagus, duodenum, and colon. The site of effervescence and drug release is chosen to correspond with the segment of the gastrointestinal tract displaying maximal absorption of the formulated drug, or to gain some other therapeutic advantage.
-
-
-
-
-
-
-
-
-